Institute seminar March 4th Guro E. Lind

Zhang X, Johannessen B, Kidd SG, Bogaard M, Stranger A, Axcrona U, Axcrona K, Skotheim RI (2026)
Cell type composition in bulk prostate cancer tissue is a prognostic biomarker
Neoplasia, 72, 101272 (in press)
DOI 10.1016/j.neo.2026.101272, PubMed 41534468

Choudhury SR, Gupta I, Mills I, Mukhina V, Loginov A, Allor E, Anderson A, Cellini A, Robles C, Dyalram D, Lubek J, Wolf J, Taylor R, Hatten K, Vorobyeva N, Gaykalova DA (2026)
HOXC6 overexpression stimulates cell migration and correlates with poor prognosis in head and neck squamous cell carcinoma
Cell Mol Life Sci (in press)
DOI 10.1007/s00018-025-06039-3, PubMed 41521225

Ghiasvand R (2026)
High-Risk Stage II Melanoma: AJCC Staging anomaly or understaging dilemma?
Br J Dermatol (in press)
DOI 10.1093/bjd/ljaf523, PubMed 41483011

Ianevski A, Nader K, Nguyen J, Sorger H, Timonen S, Julia E, Pölöske D, Spirk K, Wagner C, Jungherz D, Nakano M, Kadambat Nair S, Ianevski P, Kankainen M, Dias D, Cichońska A, Pemovska T, Pirker C, Berger W, Braun T, Moriggl R, Bachy E, Mustjoki S, Herling M, Neubauer HA et al. (2026)
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery
Cancer Res, 86 (2), 295-309
DOI 10.1158/0008-5472.CAN-25-0881, PubMed 41166698

Moura DS, Lopez-Marti J, Tawbi H, Keung E, Wani K, Lazar A, Wang WL, Ingram DR, Meza-Zepeda LA, Myklebost O, Burgess M, Mondaza-Hernandez JL, Hindi N, Martín-Broto J (2026)
Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS)
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-25-2580, PubMed 41537707

Zhang X, Johannessen B, Kidd SG, Bogaard M, Stranger A, Axcrona U, Axcrona K, Skotheim RI (2026)
Cell type composition in bulk prostate cancer tissue is a prognostic biomarker
Neoplasia, 72, 101272 (in press)
DOI 10.1016/j.neo.2026.101272, PubMed 41534468